Diminished neuronal metabolic activity in Alzheimer's disease

Journal of Neural Transmission

Volumn 106, Issue 9-10, 1999, Pages 955-986

  Salehi, A ^a,b   Swaab, D F ^a  

^a NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; ApoE; Golgi apparatus; Metabolism; Neuritic plaques; Neurofibrillary tangles; Neurotrophin; Neurotrophin receptors; NGF; Nucleus basalis; TrkA

Indexed keywords

APOLIPOPROTEIN E; PROTEIN ANTIBODY; SIALOGLYCOPROTEIN;

AGE; ALZHEIMER DISEASE; AUTOPSY; BRAIN METABOLISM; CELL METABOLISM; CONTROLLED STUDY; GENE FREQUENCY; GENETIC RISK; GOLGI COMPLEX; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; HYPOTHALAMUS; NERVE CELL; NEUROFIBRILLARY TANGLE; OLIVARY NUCLEUS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SENILE PLAQUE;

AGE FACTORS; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; BASAL NUCLEUS OF MEYNERT; GLUCOSE; GOLGI APPARATUS; HIPPOCAMPUS; HUMANS; HYPOTHALAMUS; NERVE GROWTH FACTORS; NEUROFIBRILLARY TANGLES; PHOTOTHERAPY; RISK FACTORS; SENILE PLAQUES; TRANSCUTANEOUS ELECTRIC NERVE STIMULATION;

EID: 0032751523     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020050216     Document Type: Review

References (188)

1. Airaksinen MS, Paetau A, Paljärvi L, Reinikainen K, Riekkinen P, Suomalainen R, Panula P (1991) Histamine neurons in the human hypothalamus: anatomy in normal and Alzheimer disease brains. Neuroscience 44: 465-481
2. Amaral DG, Ishizuka N, Claiborne B (1990) Neurons, numbers and the hippocampal network. In: Storm-Mathison I, Zimmer J, Ottersen OP (eds) Understanding the brain through the hippocampus. The hippocampal region as a model for studying brain structure and function. Elsevier, Amsterdam, pp 1-11 (Prog Brain Res 83)
3. Anderson FH, Richardson EP, Okasaki H, Brody JA (1979) Neurofibrillary degeneration on Guam: frequency in Chamorros and non-Chamorros with no known neurological disease. Brain 102: 65-77
4. Appel LSH (1981) Unifying hypothesis for the cause of amyotrophic lateral sclerosis, Parkinson and Alzheimer's disease. Ann Neurol 10: 499-505
5. Arendt T, Bigl V, Arendt A, Tennstedt A (1983a) Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's disease. Acta Neuropathol 61: 101-108
6. Arendt T, Zvegintseva HG, Leontovich TA (1983b) Dendritic changes in the basal nucleus of Meynert and in the diagonal band nucleus in Alzheimer's disease - a quantitative Golgi investigation. Neuroscience 19: 1265-1278
7. Arendt T, Schindler C, Brückner MK, Eschrich K, Bigl V, Zedlick D, Marcova L (1997) Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 allele. J Neurosci 17: 516-529
8. Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT (1992) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 42: 631-639
9. Bancher C, Brunner C, Lassmann H, et al (1989) Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease. Brain Res 477: 90-99
10. Bartus RT, Dean RL, Sherman KA, Friedman E, Beer B (1981) Profound effects of combining choline and piracetam on memory enhancement and cholinergic function in aged rats. Neurobiol Aging 2: 105-111
11. Beffert U, Poirier J (1996) Apolipoprotein E, plaques, tangles and cholinergic dysfunction in Alzheimer's disease. Ann NY Acad Sci 1996 17: 166-174
12. Benešová O (1994) Neuropathobiology of senile dementia and mechanism of action of nootropic drugs. Drugs Aging 4: 285-303
13. Benson DF (1998) PET/dementia: an update. Neurobiol Aging 9: 87-88
14. Benson DF, Kuhl DE, Hawkins RA, Phelps ME, Cummings JL, Tsai SY (1983) The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia. Arch Neurol 40: 711-714
15. Berg L, McKeel DW Jr, Miller JP, Baty J, Morris JC (1993) Neuropathological indexes of Alzheimer's disease in demented and nondemented persons aged 80 years and older. Arch Neurol 50: 349-358
16. Bowen DM, Smith CB, White P, Flack RH, Carrasco LH, Gedye JL, Davison AN (1977) Chemical pathology of the organic dementias. II. Quantitative estimation of cellular changes in post-mortem brains. Brain 100: 427-453
17. Bowen DM, Benton JS, Spillane, JA Smith CC, Allen SJ (1982) Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients. J Neurol Sci 57: 191-202
18. Braak H, Braak E (1992) Anatomy of the human hypothalamus (chiasmatic and tuberal region) In: Swaab DF, Hofman MA, Mirmiran M, Ravid R, Van Leeuwen FW (eds) The human hypothalamus in health and disease. Elsevier, Amsterdam, pp 3-16 (Prog Brain Res 93)
19. Bullido MJ, Artiga MJ, Recuero M, et al (1998) A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia. Nature Genet 18: 69-71
20. Byne W, Mattiace L, Kress Y, Davies P (1991) Alz-50 immunoreactivity in the hypothalamus of the normal and Alzheimer human and the rat. J Comp Neurol 306: 602-612
21. Caputo CB, Salama AI (1989) The amyloid proteins of Alzheimer's disease as potential targets for drug therapy. Neurobiol Aging 10: 451-461
22. Chao MV, Bothwell MA, Ross AH, Koprowski H, Lanahan AA, Buck CR, Sehgal A (1986) Gene transfer and molecular cloning of the human NGF receptor. Science 232: 518-521
23. Chartier-Harlin MC, Crawford F, Houlden H, et al (1991) Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene. Nature 353: 844-846
24. Coleman PD (1994) Toward rational therapy for Alzheimer's disease. Neurobiol Aging 15:S77-S78
25. Corder EH, Saunders AM, Strittmatter WJ, et al (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923
26. Corder EH, Saunders AM, Risch NJ, et al (1994) Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genet 7: 180-184
27. Corsellis JA, Bruton CJ, Freeman-Browne D (1973) The aftermath of boxing. Psychol Med 3: 270-273
28. Cotman CW, Anderson AJ (1995) A potential role for apoptosis in neurodegeneration and Alzheimer's disease. Mol Neurobiol 10: 19-45
29. Craft S, Newcomer J, Kanne S, et al (1996) Memory improvement following induced hyperinsulinemia in Alzheimer's disease. Neurobiol Aging 1: 123-130
30. Croisile B, Trillet M, Fondarai J, Laurent B, Mauguiere F, Billardon M (1993) Long-term and high-dose piracetam treatment of Alzheimer's disease. Neurology 43: 301-305
31. Croul S, Mezitis SGE, Stieber A, Chen Y, Gonatas JO, Goud B, Gonatas NK (1990) Immunocytochemical visualization of the Golgi Apparatus in several species, including human, and tissues with an antiserum against MG-160, a sialoglycoprotein of rat Golgi apparatus. J Histochem Cytochem 38: 957-963
32. Crucio CA, Kemper T (1984) Nucleus raphe dorsalis in dementia of the Alzheimer type: neurofibrillary changes and neuronal changes and neuronal packing density. J Neuropathol Exp Neurol 43: 359-368
33. Crutcher KA, Scott SA, Liang S, Everson WV, Weingartner J (1993) Detection of NGF-like activity in human brain tissue: increased levels in Alzheimer's disease. J Neurosci 13: 2540-2550
34. Cutler NR, Haxby JV, Duara R, et al (1985) Clinical history, brain metabolism, and neuropsychological function in Alzheimer's disease. Ann Neurol 18: 298-309
35. Davies P (1989) A different view of A68 and amyloid. Neurobiol Aging 10: 408-409
36. Davis KL (1989) Toward a therapeutic strategy based on amyloid precursor protein: unanswered questions. Neurobiol Aging 10: 475-476
37. Dawbarn D, Allen SJ, Semenenko FM (1988) Coexistence of choline acetyltransferase and nerve growth factor receptors in the rat basal forebrain. Neurosci Lett 94: 138-144
38. Dayan AD, Ball MJ (1973) Histometric observations on the metabolism of tangle-bearing neurons. J Neurol Sci 19: 433-436
39. De Leon MJ, Ferris SH, George AE, et al (1983) Positron emission tomographic studies of aging and Alzheimer's disease. Am J Neuroradiol 4: 563-571
40. Doebler JA, Markesbery WR, Anthony A, Rhoads RE (1987) Neuronal RNA in relation to neuronal loss and neurofibrillary pathology in the hippocampus in Alzheimer's disease. J Neuropathol Exp Neurol 46: 28-39
41. Duyckaerts C, Delaere P, Hauw JJ, et al (1990) Rating of the lesions in senile dementia of the Alzheimer type: concordance between laboratories. A European multicenter study under the auspices of EURAGE. J Neurol Sci 97: 295-323
42. Eagger SA, Levy R, Sahakian BJ (1991) Tacrine in Alzheimer's disease. Lancet 338: 50-51
43. Etienne P, Robitaille Y, Wood P, Gauthier S, Nair NPV, Quirion R (1986) Nucleus basalis neuronal loss, neuritic plaques and choline acetyltransferase activity in advanced Alzheimer's disease. Neuroscience 19: 1279-1291
44. Farquhar MG (1985) Progress in unravelling pathways of Golgi traffic. Annu Rev Cell Biol 1: 447-486
45. Farquhar MG, Palade G (1981) The Golgi apparatus (complex) (1951-1981): from artifact to center stage. J Cell Biol 91: 77s-103s
46. Fawcett DW (1966) An atlas of fine structures. The cell and its organelles as inclusions. Saunders, Philadelphia
47. Fischer W, Bjorklund A, Chen K, Gage FH (1991) NGF improves spatial memory in aged rodents as a function of age. J Neurosci 11: 1889-1906
48. Fliers E, Swaab DF, Pool CW, Verwer RWH (1985) The vasopressin and oxytocin neurons in the human supraoptic and paraventricular nucleus; changes with aging and in senile dementia. Brain Res 342: 45-53
49. Foster N, Chase TN (1986) Cerebral metabolic rate of glucose and Alzheimer's disease. J Cereb Blood Flow Metab 6: 125-127
50. Fujii M (1982) Cyto-and myeloarchitectural studies on the lateral tuberal nucleus in simian Callithricidae and Prosimiae. Acta Anat 114: 155-164
51. Gauthier S, Bouchard R, Lamontagne A, et al (1990) Tetrahydroaminoacridine-lecithin combination treatment in patients with intermediate-stage Alzheimer's disease. Results of a Canadian double-blind, crossover, multicenter study. N Engl J Med 322: 1272-1276
52. Gertz HJ, Schoknecht G, Kruger H, Cervos-Navarro J (1989) Stability of cell size and nucleolar size in tangle-bearing neurons of the hippocamus in Alzheimer's disease. Brain Res 487: 373-375
53. Giurgea M (1977) Piracetam: toxicity and reproduction studies. Farmaco [Prat] 32: 47-52
54. Gnahn H, Hefti F, Heumann R, Schwab ME, Thoenen H (1983) NGF-mediated increase of choline acelyltransferase (ChAT) in the neonatal rat forebrain: evidence for a physiological role of NGF in the brain? Brain Res 285: 45-52
55. Goate A, Chartier-Harlin M-C, Mullan M, et al (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349: 704-706
56. Goedert M, Fine A, Hunt SP, Ullrich A (1986) Nerve growth factor mRNA in peripheral and central rat tissues and in the human central nervous system: lesion effects in the rat brain and levels in Alzheimer's disease. Brain Res 1: 85-92
57. Goedert M, Fine A, Dawbarn D, Wilcock GK, Chao MV (1989) Nerve growth factor receptor mRNA distribution in human brain: normal levels in basal forebrain in Alzheimer's disease. Mol Brain Res 5: 1-7
58. Gomez-Isla T, Hyman BT (1996) Connections and cognitive impairment in Alzheimer's disease. In: Hyman BT, Duyckaerts C, Christen Y (eds) Connection, cognition and Alzheimer's disease. Springer, Berlin Heidelberg New York Tokyo, pp 149-166
59. Gonatas JO, Mezitis SGE, Stieber A, Fleischer B, Gonatas NK (1989) MG-160. A novel sialoglycoprotein of the medial cisternae of the Golgi apparatus. J Biol Chem 264: 646-653
60. Gonatas JO, Mourelatos Z, Stieber A, Lane WS, Brosius J, Gonatas NK (1995) MG-160, a membrane sialoglycoprotein of the medial cisternae of the rat Golgi apparatus, binds basic fibroblast growth factor and exhibits a high level of sequence identity to a chicken fibroblast factor receptor. J Cell Sci 108: 457-467
61. Grundke-Iqbal I, Iqbal K, Tung YC, Ouinlan M, Wisniewski HM, Binder LI (1986) Abnormal phosphorylation of the microtubule-associatcd protein tau (tau) in Alzheimer cytoskelelal pathology. Proc Natl Acad Sci U S A 83: 4913-4917
62. Guillemette JG, Wong L, Crapper McLachlan DR, Lewis PN (1986) Characterization of messenger RNA from the cerebral cortex of control and Alzheimer-afflicted brain. J Neurochem 47: 987-997
63. Hammerschlag R, Stone GC, Bolen FA, Lindsey JD, Ellisman MH (1982) Evidence that all newly synthesized proteins destined for fast axonal transport pass through the Golgi apparatus. J Cell Biol 93: 568-575
64. Hatanpää K, Chandrasekaran K, Brady DR, Papoport ST (1998) No association between Alzheimer plaques and decreased levels of cytochrome oxidase subunit mRNA, a marker of neuronal energy metabolism. Mol Brain Res 59: 13-21
65. Hefti F (1986) Nerve growth factor promotes survival of septal cholinergic neurons of the fimbrial transcctions. J Neurosci 6: 2155-2162
66. Hefti F, Weiner WJ (1986) Nerve growth factor and Alzheimer's disease. Ann Neurol 20: 275-281
67. Hefti F, Mash DC (1989) Localization of nerve growth factor receptors in the normal human brain and in Alzheimer's disease. Neurobiol Aging 10: 75-87
68. Heiss WD, Hebold I, Klinkhammer P, Ziffling P, Szelics B, Pawlik G, Herholz K (1988) Effect of piracetam on cerebral glucose metabolism in Alzheimer's disease as measured by positron emission tomography. J Cereb Blood Flow Metab 8: 613-617
69. Higgins GA, Mufson EJ (1989) NGF receptor gene expression is decreased in the nucleus basalis in Alzheimer's disease. Exp Neurol 106: 222-236
70. Hofman MA, Fliers E, Goudsmit E, Swaab DF (1988) Morphometric analysis of the suprachiasmatic and paraventricular nuclei in the human brain: sex differences and age-dependent changes. J Anat 160: 127-43
71. Hoogendijk JE, Fliers E, Swaab DF, Verwer RW (1985) Activation of vasopressin neuron in the human supraoptic and paraventricular nucleus in senescence and senile dementia. J Neurol Sci 69: 291-299
72. Hoogendijk WJ, Pool CW, Troost D, Van Zwieten E, Swaab DF (1995) Image analyser-assisted morphometry of the locus coeruleus in Alzheimer's disease, Parkinson's disease and amyotrophic sclerosis. Brain 118: 131-143
73. Hoyer S (1993) Brain oxidative energy and related metabolism, neuronal stress, and Alzheimer's disease: a speculative synthesis. J Geriatr Psychiatry Neurol 6: 3-13
74. Hoyer S, Oesterreich K, Wagner O (1988) Glucose metabolism as the site of the primary abnormality in early-onset dementia of Alzheimer type? J Neurol 235: 143-148
75. Iqbal K, Grundke-Iqbal I, Merz PA, Wisniewski HM, Zaidi T (1987) In vitro assembly and isolation of neurofilaments and microtubules from mammalian CNS. Brain Res 388: 163-172
76. Kang J, Lemaire HG, Unterbeck A, et al (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325: 733-736
77. Kaplan DR, Martin-Zanca D, Parada LF (1991) Tyrosine phosphorylation and tyrosine kinase activity of the trk proto-oncogene product by NGF. Nature 350: 158-160
78. Katzman R (1976) The prevalence and malignancy of Alzheimer's disease. Arch Neurol 33: 217-218
79. Klein R, Nanduri V, Jing S, et al (1991) The trkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3. Cell 66: 395-403
80. Klein R, Smeyne RJ, Wurst W, Long LK, Auerbach BA, Joyner AL, Barbacid M (1993) Targeted disruption of the trkB neurotrophin receptor gene results in nervous system lesions and neonatal death. Cell 75: 113-132
81. Koliatsos VE, Price DL, Gouras GK, Cayouette MH, Burton LE, Winslow JW (1994) Highly selective effects of nerve growth factor, brain-derived neurotrophic factor, and neurotrophin-3 on intact and injured basal forebrain magnocellular neurons. J Comp Neurol 343: 247-262
82. Korsching S, Auburger G, Heumann R, Scott J, Theonen H (1985) Levels of nerve growth factor and its mRNA in the cental nervous system of the rat correlate with cholinergic innervation. EMBO J 4: 1389-1393
83. Kremer B, Swaab D, Bots G, Fisser B, Ravid R, Roos RAC (1991) The hypothalamic lateral tuberal nucleus in Alzheimer's disease. Ann Neurol 29: 279-284
84. Ksiezak-Reding H, Binder LI, Yen S-H (1990) Alzheimer's disease proteins (A68) share epitopes with tau but show distinct biochemical properties. J Neurosci Res 25: 420-430
85. Lamballe F, Klein R, Barbacid M (1991) trkC, a new member of the family of tyrosine protein Kinases, is a receptor for neurotrophin-3. Cell 66: 967-979
86. Larson EB, Kukull WA, Katzman RL (1992) Cognitive impairment: dementia and Alzheimer's disease. Ann Rev Pub Health 501: 431-449
87. Levy-Lahad E, Wijsman EM, Nemens E, et al (1995) A familial Alzheimer's disease locus on chromosome 1. Science 269: 970-973
88. Li Y, Holtzman DM, Kromer LF, et al (1995) Regulation of TrkA and ChAT expression in developing rat basal forebrain: evidence that both exogenous and endogenous NGF regulate differentiation of cholinergic neurons. J Neurosci 15: 2888-28905
89. Lovestone S, Anderton BH, Hartley C, Jensen TG, Jorgensen AL (1996) The intracellular fate of apolipoprotein E is tau dependent and apoe allele-specific. NeuroReport 7: 1005-1008
90. Lucassen PJ, Salehi A, Pool CW, Gonatas NK, Swaab DF (1994) Activation of vasopressin neurons in aging and Alzheimer's disease. J Neuroendocrinol 6: 673-679
91. Mahley RW (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240: 622-630
92. Mann DM, Yates PO (1981) The relationship between formation of senile plaques and neurofibrillary tangles and changes in nerve cell metabolism in Alzheimer type dementia. Mech Ageing Dev 17: 395-401
93. Mann DMA, Neary D, Yates PO, Lincoln J, Snowden JS, Stanworth P (1981) Alterations in protein synthetic capability of nerve cells in Alzheimer's disease. J Neurol Neurosurg Psychiatr 44: 97-102
94. Manning CA, Rogozzino ME, Gold PE (1993) Glucose enhancement of memory in patients with probable senile dementia of the Alzheimer's type. Neurobiol Aging 14: 523-528
95. Masliah E, Mallory M, Ge N, Alford M, Veinbergs I, Roses AD (1995) Neurodegeneration in the central nervous system of ApoE-deficient mice. Exp Neurol 136: 107-122
96. Masliah E, Mallory M, Alford M, DeTerwesa R, Iwai A, Saitoh T (1997) Molecular mechanisms of synaptic disconnection in Alzheimer's disease. In: Hyman BT, Duyckaerts C, Christen Y (eds) Connection, cognition and Alzheimer's disease. Springer, Berlin Heidelberg New York Tokyo, pp 121-140
97. McGeer PL, Rogers J (1992) Anti-inflammatory agents as a therapeutic approach to Alzheimer's disease. Neurology 42: 447-479
98. McGeer PL, Kamo H, Harrop R, et al (1986) Positron emission tomography in patients with clinically diagnosed Alzheimer's disease. Can Med Assoc J 134: 597-607
99. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health, Human Service Task Force on Alzheimer's Disease. Neurology 34: 939-944
100. Meakin SO, Suter U, Drinkwater CC, Welcher AA, Shooter EM (1992) The rat trk protooncogene product exhibits properties characteristic of the slow nerve growth factor receptor. Proc Natl Acad Sci USA 89: 2374-2378
101. Meier-Ruge W, Bertoni-Freddari C, Iwangoff P (1994) Changes in brain glucose metabolism as a key to the pathogenesis of Alzheimer's disease. Gerontology 40: 246-252
102. Mega MS, Chen SS, Thompson PM, et al (1997) Mapping histology to metabolism: coregistration of stained whole-brain sections to premortem PET in Alzheimer's disease. Neuroimage 5: 147-153
103. Meneilly GS, Hill A (1993) Alterations in glucose metabolism in patients with Alzheimer's disease. J Am Geriatr Soc 41: 710-714
104. Mesulam MM, Musfan EJ, Levey AI, Wainer BH (1984) Atlas of cholinergic neurons in the forebrain and upper brainstem of the macaque based on monoclonal choline acetyltransferase immunohistochemistry and acetylcholinesterase histochemistry. Neuroscience 12: 669-686
105. Mielke R, Zerres K, Uhlhaas S, Kessler J, Heiss WD (1998) Apolipoprotein E polymorphism influences the cerebral metabolic pattern in Alzheimer's disease. Neurosci Lett 254: 49-52
106. Mishima K, Okawa M, Hishikawa Y, Hozumi S, Hori H, Takahashi K (1994) Morning bright light therapy for sleep and behavior disorders in elderly patients with dementia. Acta Psychiatr Scand 89: 1-7
107. Mobley WC, Rutkowski JL, Tennekoon GT, Gemski J, Buchanan K, Johnston MV (1986) Nerve growth factor increases choline acetyltransferase activity in developing basal forebrain neurons. Brain Res 387: 53-62
108. Mufson EJ, Presley LN, Kordower JH (1991) Nerve growth factor receptor immunoreactivity within nucleus basalis (Ch4) in Parkinson's disease: reduced cell number and co-localization with cholinergic neurons. Brain Res 539: 19-30
109. Mullan M (1992) Familial Alzheimer's disease: second gene locus located. BMJ 305: 1108-1109
110. Murase K, Nabeshima T, Robitaille Y, Quirion R, Ogawa M, Hayashi K (1993) NGF level of is not decreased in the serum, brain-spinal fluid, hippocampus, or parietal cortex of individuals with Alzheimer's disease. Biochem Biophys Res Commun 193: 198-203
111. Murase K, Nabeshima T, Robitaille Y, Quirion R, Ogawa M, Hayashi K (1993) NGF level of is not decreased in the serum, brain-spinal fluid, hippocampus, or parietal cortex of individuals with Alzheimer's disease. Biochem Biophys Res Commun 193: 198-203
112. Nakamura S, Takemura M, Ohnishi K, et al (1993) Loss of large neurons and occurrence of neurofibrillary tangles in the tuberomammillary nucleus of patients with Alzheimer's disease. Neurosci Lett 151: 196-199
113. Nicholson CD (1989) Nootropics and metabolically active compounds in Alzheimer's disease. Biochem Soc Trans 17: 83-85
114. Okawa M, Mishima K, Hishikawa Y, Hozumi S, Hori H, Takahashi K (1991) Circadian rhythm disorders in sleep-waking and body temperature in elderly patients with dementia and their treatment. Sleep 14: 478-485
115. Ordovas JM, Lilwack-Klein L, Wilson PW, Schaefer MM, Schaefer EJ (1987) Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoE1 and apoE5 isoforms. J Lipid Res 28: 371-383
116. Ott A, Breteler MM, Van Harskamp F, et al (1995) Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study. BMJ 310: 970-973
117. Palmer AM, Procter AW, Stratmann GC, Bowen DM (1986) Excitatory amino acid-releasing and cholinergic neurons in Alzheimer's disease. Neurosci Lett 66: 199-204
118. Pearson RC, Sofroniew MV, Cuello AC, Powell TP, Eckenstein F, Esiri MM, Wilcock GK (1983) Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase. Brain Res 289: 375-379
119. Pericak-Vance MA, Bebout JL, Gaskell PC, et al (1991) Linkage studies in familial Alzheimer's disease: evidence for chromosome 19 linkage. Am J Hum Genet 48: 1034-1054
120. Poirier J, Davignon J, Bouthiller D, Kogan S, Bertrand P, Gauthier S (1993) Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342: 697-699
121. Poirier J, Delisle M-C, Quirion R, et al (1995) Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. Proc Natl Acad Sci U S A 92: 12260-12264
122. Price JL (1993) The relationship between tangle and plaque formation during healthy aging and mild dementia. Neurobiol Aging 14: 661-663
123. Rebeck GW, Perls TT, West HL, Sodhi P, Lipsitz LA, Hyman BT (1994) Reduced apolipoprotein epsilon 4 alleles frequency in the oldest old Alzheimer's patients and cognitively normal individuals. Neurology 144: 1513-1516
124. Regeur L, Jensen GB, Pakkenberg H, Evans SM, Pakkenberg B (1994) No global neocortical nerve cell loss in brains from patients with senile dementia of Alzheimer's type. Neurobiol Aging 15: 347-352
125. Reiman EM, Caselli RJ, Yun LS, et al (1996) Preclinical evidence of Alzheimer's disease in persons homozygout for the E4 allele for apolipoprotein E. N Engl J Med 334: 752-758
126. Reisberg B, Ferris FH, De Leon MJ, Crook T (1982) The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 139: 1136-1139
127. Richter JA, Perry EK, Tomlinson BE (1980) Acctylcholine and choline levels in postmortem human brain tissue: preliminary observations in Alzheimer's disease. Life Sci 26: 1683-1689
128. Rinne JO, Paljärvi L, Rinne UK (1987) Neuronal size and density in the nucleus basalis of Meynert in Alzheimer's disease. J Neurol Sci 79: 67-76
129. Rogaev EI, Sherrington R, Rogaeva EA, et al (1995) Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376:775-778
130. Roses AD (1994) Apolipoprotein E affects the rate of Alzheimer disease expression: β-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. J Neuropathol Exp Neurol 53: 429-437
131. Rossor MN, Svendsen C, Hunt SP, Mountjoy CO, Roth M, Iversen LL (1982) The substantia innominata in Alzheimer's disease: an histochemical and biochemical study of cholinergic marker enzymes. Neurosci Lett 28: 217-222
132. Rossor MN, Fox NC, Beck J, Campbell TC, Collinge J (1996) Incomplete penetrance of familial Alzheimer's disease in a pedigree with a novel presenilin-1 gene mutation. Lancet 347: 1560
133. Rylett RJ, Ball MJ, Colhoun EH (1983) Evidence for high affinity choline transport in synaptosomes prepared from hippocampus and neocortex of patients with Alzheimer's disease. Brain Res 289: 169-175
134. Sajdel-Sulkowska EM, Marotta CA (1984) Alzheimer's disease brain: alterations in RNA levels and in a ribonuclease-inhibitor complex. Science 31: 947-949
135. Sajdel-Sulkowska EM, Coughlin JF, Staton DM, Marotta CA (1993) In vitro protein synthesis by messenger RNA from the Alzheimer's disease brain. In: Katzman R (ed) 193-300 Banbury Report 15: Biological aspects of Alzheimer's disease. Cold Spring Harbor Lab, New York
136. Salehi A, Lucassen PJ, Pool CW, Gonatas NK, Ravid R, Swaab DF (1994) Decreased neuronal activity in the nucleus basalis of Meynert in Alzheimer's disease as suggested by the size of the Golgi apparatus. Neuroscience 4: 871-880
137. Salehi A, Van de Nes JAP, Hofman MA, Gonatas NK, Swaab DF (1995a) Early cytoskeletal changes as shown by Alz-50 are not accompanied by decreased neuronal activity. Brain Res 678: 29-39
138. Salehi A, Ravid R, Gonatas NK, Swaab DF (1995b) Decreased activity of the hippocampal neurons in Alzheimer's disease is not related to the presence of the neurofibrillary tangles. J Neuropathol Expl Neurol 54: 704-709
139. Salehi A, Heyn S, Gonatas NK, Swaab DF (1995c) Decreased protein synthetic activity of the hypothalamic tuberomamillary nucleus in Alzheimer's disease as suggested by the size of the Golgi apparatus. Neurosci Lett 193: 1-4
140. Salehi A, Verhaagen J, Dijkhuizen PA, Swaab DF (1996) Colocalization of high affinity neurotrophin receptors in nucleus basalis of Meynert neurons and their differential reduction in Alzheimer's disease. Neuroscience 75: 373-387
141. Salehi A, Bakker JM, Mulder M, Swaab DF (1998a) Limited effects of neuritic plaques on neuronal density on the hippocampal CA1 area of Alzheimer patients. Alzheimer Dis Assoc Disord 12: 77-82
142. Salehi A, Dubelaar EJG, Mulder M, Swaab DF (1998b) Aggravated decrease in the activity of nucleus basalis neurons in Alzheimer's disease is apolipoprotein E-type dependent. Proc Natl Acad Sci USA 95: 11445-11449
143. Salehi A, Verhaagen J, Swaab DF (1998c) Neurotrophin receptors in Alzheimer's disease. In: Van Leeuwcn FW, Salehi A, Giger RJ, Holtmaat AJGD, Verhaagen J (eds) Neuronal degeneration and regeneration: from basic mechanisms to prospects for therapy. Elsevier, Amsterdam, pp 71-89 (Prog Brain Res 117)
144. Salehi A, Pool CW, Mulder M, Gonatas NK, Swaab DF (1998d) Activity of hippocampal CA1 neurons in Alzheimer's disease is not affected by the presence of adjacent neuritic plaques. J Alz Dis 1: 107-118
145. Saper CB (1990) Hypothalamus. In: Paxinos G (ed) Human nervous system. Academic Press, New York, pp 389-413
146. Saper CB, German DC (1987) Hypothalamic pathology in Alzheimer's disease. Neurosci Lett 74: 364-370
147. Saunders AM, Schmader K, Breitner JC, et al (1993) Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet 342: 710-711
148. Schächter F, Faure-Delanef L, Guénot F, Rouger H, Froguel P, Lesueur-Ginot L, Cohen D (1994) Genetic associations with human longevity at the APOE and ACE loci. Nature Genet 6: 29-32
149. Schenk DB, Rydel RE, May P, Little S, Panetta J, Lieberburg I, Sinha S (1995) Therapeutic approaches related to amyloid-beta peptide and Alzheimer's disease. J Med Chem 38: 4141-4154
150. Schneider LS, Tariot PN (1994) Emerging drugs for Alzheimer's disease. Mechanisms of action and prospects for cognitive enhancing medications. Med Clin North Am 8: 911-934
151. Scherder E, Bouma A, Steen A, Swaab D (1995a) Peripheral nerve stimulation in Alzheimer's disease. A meta-analysis. Alz Res 1: 183-184
152. Scherder E, Bouma A, Steen A (1995b) Effects of simultaneously applied short-term transcutaneous electric nerve stimulation and tactile stimulation on memory and affective behaviour of patients with probable Alzheimer's disease. Behav Neurol 8: 3-13
153. Scherder EJA, Bouma A, Steen AM (1995c) Effects of short-term transcutaneous electric nerve stimulation on memory and affective behaviour in patients with probable Alzheimer's disease. Behav Brain Res 67: 211-219
154. Schultz C, Koppers D, Braak H, Braak E (1997) Cytoskeletal alterations in the aged human neurohypophysis. Neurosci Lett 237: 93-96
155. Seiger Å, Nordberg A, von Holst H, et al (1993) Intracranial infusion of purified nerve growth factor to an Alzheimer patient: the first attempt of a possible future treatment strategy. Behav Brain Res 57: 255-261
156. Seiler M, Schwab ME (1984) Specific retrograde transport of nerve growth factor (NGF) from neocortex to nucleus basalis in the rat. Brain Res 300: 33-39
157. Selkoe DJ (1994) Alzheimer's disease: a central role for amyloid. J Neuropathol Exp Neurol 53: 438-447
158. Schellenberg GD, Bird TD, Wijsman EM, et al (1992) Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science 258: 668-671
159. Sherrington R, Rogaev EI, Liang Y, et al (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375: 754-760
160. Simonian NA, Hyman BT (1993) Functional alterations in Alzheimer's disease: diminution of cytochrome oxidase in the hippocampal formation. J Neuropathol Exp Neurol 52: 580-585
161. Simonian NA, Hyman BT (1994) Functional alterations in Alzheimer's disease: selective loss of mitochondrial-encoded cytochrome oxidase mRNA in the hippocampal formation. J Neuropathol Exp Neurol 53: 508-512
162. Soininen HS, Riekkinen Sr PJ (1996) Apolipoprotein E, memory and Alzheimer's disease. Trends Neurosci 19: 224-228
163. Soppet D, Escandon E, Maragos J, et al (1991) The neurotrophic factor brain-derived neurotrophic factor and neurotrophin-3 are ligands for the trkB tyrosine kinase receptor. Cell 65: 895-903
164. Stieber A, Mourelatos Z, Chen Y-J, Le Douarin N, Gonatas NK (1995) MG160, a membrane protein of the Golgi apparatus which is homologous to a fibroblast growth factor receptor and to a ligand for E-selectin, is found only in the Golgi apparatus and appears early in chicken embryo development. Exp Cell Res 219: 562-570
165. Swaab DF (1991) Brain aging and Alzheimer's disease, "wear and tear" versus "use it or lose it". Neurobiol Aging 12: 317-324
166. Swaab DF (1992) How to prevent the retiring brain from degenerating. Clin Neurol Neurosurg 94 [Suppl]: S150-152
167. Swaab DF, Jongkind JF (1970) The hypothalamic neurosecretary activity during the oestrous cycle, pregnancy, parturition, lactation and persistent oesterus and after gonadectomy, in the rat. Neuroendocrinology 6: 133-145
168. Swaab DF, Grundke-Iqbal I, Iqbal K, Kremer HP, Ravid R, Van de Nes J (1992) Tau and ubiquitin in the human hypothalamus in aging and disease. Brain Res 590: 239-249
169. Swaab DF, Hofman MA, Lucassen PJ, Purba JS, Raadsheer FC, Van de Nes JAP (1993) Functional neuroanatomy and neuropathology of the human hypothalamus. Anat Embryol 187: 317-330
170. Swaab DF, Hofman MA, Lucassen PJ, Salehi A, Uylings HB (1994) Neuronal atrophy, not cell death, is the main hallmark of Alzheimer's disease. Neurobiol Aging 15: 369-371
171. Swanson LW, Sawchenko PE (1983) Hypothalamic integration: organization of the paraventricular and supraoptic nuclei. Ann Rev Neurosci 6: 269-324
172. Swerdlow R, Marcus DL, Landman J, Kooby D, Frey W, Freedman ML (1994) Brain glucose metabolism in Alzheimer's disease. Am J Med Sci 308: 141-144
173. Talbot C, Lendon C, Craddock N, Shears S, Morris JC, Goate A (1994) Protection against Alzheimer's disease with apoE epsilon 2. Lancet 343: 1432-1433
174. Tanzi RE, Haines JL, Watkins PC, et al (1988) Genetic linkage map of human chromosome 21. Genomics 3: 129-136
175. Taylor GR, Carter GI, Crow TJ, Johnson JA, Fairbairn AF, Perry EK, Perry RH (1986) Recovery and measurement of specific RNA species from postmortem brain tissue: a general reduction in Alzheimer's disease detected by molecular hybridization. Exp Mol Pathol 44: 111-116
176. Ulfig N, Braak H (1989) Amyloid deposits and neurofibrillary changes in the hypothalamus tuberomamillary nucleus. J Neural Transm 1: 143
177. Van Broekhoven C (1995) Presenilins and Alzheimer disease. Nature Genet 11: 230-232
178. Van de Nes JAP, Kamphorst W, Ravid R, Swaab DF (1993) The distribution of Alz-50 immunoreactivity in the hypothalamus and adjoining areas of Alzhieimer's disease patients. Brain 116: 103-115
179. Van Duijn CM (1996) Epidemiology of the dementias: recent developments and new approaches. J Neurol Neurosurg Psychiatry 60: 478-488
180. Van Hoesen GW, Hyman RT (1990) Hippocampal formation: anatomy and the patterns of pathology in Alzheimer's disease. In: Storm-Mathisen J, Zimmer J, Ottersen OP (eds) Understanding the brain through hippocampus. The hippocampal region as a model for studying brain structure and function. Elsevier, Amsterdam, pp 445-457 (Prog Brain Res 83)
181. Van der Woude PF, Goudsmit E, Wierda M, Purba JS, Hofman MA, Bogte H, Swaab DF (1995) No vasopressin cell loss in the human hypothalamus in aging and Alzheimer's disease. Neurobiol Aging 16: 11-18
182. Verde C, Pascale MC, Martire G, Lotti LV, Torrisi MR, Helenius A, Bonatti S (1995) Effect of ATP depletion and DTT on the transport of membrane proteins from the endoplasmic reticulum and the intermediate compartment to the Golgi complex. Eur J Cell Biol 67: 267-274
183. West MJ, Coleman PD, Flood DG, Troncoso JC (1994) Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease. Lancet 344: 769-772
184. Whitehouse PJ, Price DL, Clark AW, Coyle JT, DeLong MR (1981) Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol 10: 122-126
185. Whittemore SR, Ebendal T, Lärkfors L, Olson L, Seiger A, Strömberg I, Persson H (1986) Development and regional expression of beta nerve growth factor messenger RNA and protein in the rat central nervous system. Proc Natl Acad Sci USA 83: 817-821
186. Wierda M, Goudsmit E, Van der Woude PF, Purba JS, Hofman MA, Bogte H, Swaab DF (1991) Oxytocin cell number in the human paraventricular nucleus remains constant with aging and Alzheimer's disease. Neurobiol Aging 12: 511-516
187. Witting W, Kwa IH, Eikelenboom P, Mirmiran M, Swaab DF (1990) Alterations in the circadian rest-activity rhythm in aging and Alzheimer's disease. Biol Psychiatry 27: 563-572
188. Wolozin BL, Pruchnicki A, Dickson DW, Davies P (1986) A neuronal antigen in the brains of Alzheimer patients. Science 232: 648-650